Italy · Delayed Price · Currency is EUR Ulisse Biomed Company Description
Ulisse Biomed S.p.A., a healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy.
The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of Sars-CoV-2 variants; and UlisseFaster, a reagent for the pre-treatment of biological samples.
It provides various tests and reagents for sexually transmitted diseases and HPV. In addition, the company’s platforms also comprise NanoHybrid, a platform to detect specific antibodies and protein analytes directly from serum or whole blood; and Aptavir platform to develop and produce synthetic nucleic acid molecules to limit the infectivity of pathogens.
Ulisse Biomed S.p.A. was founded in 2015 and is based in Udine, Italy.
| Country | Italy |
| Founded | 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 22 |
| CEO | Nicola Basile |
Contact Details
Address: Via Cavour, 20 Udine, 33100 Italy | |
| Phone | 39 04 03 75 75 40 |
| Website | ulissebiomed.com |
Stock Details
| Ticker Symbol | UBM |
| Exchange | Borsa Italiana |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | IT0005451213 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Nicola Basile | Chief Executive Officer and Director |
| Bruna Marini | Co-founder, Chief Operating Officer and Executive Director |
| Rudy Ippodrino | Co-Founder and Chief Scientific Officer |
| Ferdinando Giuliani | Head of Business Development |
| Carlo Montenovesi | Executive Director |